Asacol and Eye movement disorder - a phase IV clinical study of FDA data

Summary:

Eye movement disorder is reported as a side effect among people who take Asacol (mesalamine), especially for people who are male, 30-39 old, also take Inflectra, and have Fibromyalgia.

The phase IV clinical study analyzes which people have Eye movement disorder when taking Asacol. It is created by eHealthMe based on reports of 19,898 people who have side effects when taking Asacol from the FDA, and is updated regularly.

What is Asacol?

Asacol has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 20,618 Asacol users. Check the latest studies of Asacol.

What is Eye movement disorder?

Eye movement disorder is found to be associated with 609 drugs and 902 conditions by eHealthMe. Check the latest studies of Eye movement disorder.

On Jul, 12, 2026

19,898 people reported to have side effects when taking Asacol.
Among them, 12 people (0.06%) have Eye movement disorder.

Could Asacol cause Eye movement disorder?

Among these 12 people:

What is the gender of people who have Eye movement disorder when taking Asacol? *

female: 0.0 %
male: 100 %

What is the age of people who have Eye movement disorder when taking Asacol? *

What are other drugs people take besides Asacol? *

Inflectra: 8 people, 66.67%
Velcade: 1 person, 8.33%
Ultram: 1 person, 8.33%
Remicade: 1 person, 8.33%

What are other side effects people have besides Eye movement disorder? *

Incoherent (talking in a confused and unclear way): 11 people, 91.67%
Paleness (unusual lightness of skin colour): 11 people, 91.67%
Dizziness: 11 people, 91.67%
Heart Rate Decreased: 11 people, 91.67%
Hyperhidrosis (abnormally increased sweating): 11 people, 91.67%
Hypotension (abnormally low blood pressure): 11 people, 91.67%
Muscle Rigidity (muscle stiffness): 11 people, 91.67%
Abnormal Behavior: 11 people, 91.67%
Unresponsive To Stimuli: 11 people, 91.67%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 11 people, 91.67%

What are the existing conditions these people have? *

Pain: 1 person, 8.33%
Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Asacol and have Eye movement disorder?

- Check whether Eye movement disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Asacol:

Asacol (20,618 reports)

Browse all side effects of Asacol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye movement disorder:

Eye movement disorder (609 drugs)

Browse all the conditions that are associated with Eye movement disorder:

Eye movement disorder (902 conditions)

Related publications that referenced our studies

Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on mesalamine (the active ingredients of Asacol) and Asacol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.